BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00095459
First received: November 4, 2004
Last updated: May 31, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2012 |
| Primary Completion Date: | November 2005 (Final data collection date for primary outcome measure) |